Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+
First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters Reinvigoration of immune system + turning cold tumors hot Preliminary ex-vivo data in HER2+ patients...
Internet Watch Foundation and Public Interest Registry Extend Online Safety Initiative to Disrupt Criminal 'brands' Selling Child Sexual Abuse
A new sponsorship programme aims to help domain registrars 'disrupt' criminal businesses Criminals running commercial child sexual abuse websites will be targeted under a new safety initiative which aims to disrupt their ability to buy domain names...